Announcements Trials
Browse Landscape

Status

Recruiting 2Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Observational 4Interventional 3

Sponsor

Cancer Type

Gastrointestinal 44Thoracic 17Genitourinary 13Breast 13Lymphoid 10Gynecologic 10Other hematologic neoplasm 8Head & Neck 8Sarcoma 7CNS 5Tumor-Agnostic 4Endocrine 4Other 3Myeloid 3Dermatologic 3Plasma cell 2Classical hematology 2Other solid neoplasm 1Other neoplasm 1

Conditions

Neoplasms 4

Interventions

Surveys and Questionnaires 48Blood Specimen Collection 22Interviews as Topic 14Data Collection 11Magnetic Resonance Spectroscopy 6Hematologic Tests 6Specimen Handling 5Restraint, Physical 5Radiotherapy 5Palliative Care 4Observation 4Mental Status and Dementia Tests 4Watchful Waiting 3Registries 3Quality of Life 3Phlebotomy 3Neoadjuvant Therapy 3Magnetic Resonance Imaging 3Lapatinib 3Immunotherapy 3Immune Checkpoint Inhibitors 3Health Records, Personal 3Focus Groups 3Drug Therapy 3Bevacizumab 3Absorptiometry, Photon 3veliparib 2talazoparib 2rucaparib 2pamiparib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Observation × Tumor-Agnostic × Clear all
NCT07501871 2026-04-21

DMU-CH

Fenerbahce University

Not yet recruiting
80 enrolled
Tumor-Agnostic

Neoplasms

NCT05061342 2026-01-27

TQ-BIRD

The University of Hong Kong-Shenzhen Hospital

Recruiting
5,000 enrolled
Tumor-Agnostic

Neoplasms

NCT06868355 2025-08-14

APACE

University of Manchester

Recruiting
40 enrolled
Tumor-Agnostic

Neoplasms

NCT04060290 2024-02-28

Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed
1,000 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡